Economical growth, observed in most countries (e.g. China, India and many others) and even in whole continents (like Africa) that were previously regarded as undeveloped and poor, resulted in an increase of global prevalence of obesity, and subsequently of increasing incidence and prevalence of diabetes. Published in 2011 prognosis predict that the prevalence of diabetes of half a billion patients in the year 2030.
1. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: General Information and National Estimates on Chronic Kidney Disease in the United States, 2010. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. http://www.cdc.gov/diabetes/pubs/factsheets/kidney.htm. Accessed November 14, 2012.
2. Koro CE, Lee BH, Bowlin SJ: Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther 2009; 31(11): 2608-2617.
3. Thomas MC, Weekes AJ, Broadley OJ et al.: The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 2006; 185(3): 140-144.
4. Go AS, Chertow GM, Fan D et al.: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351(13): 1296-1305.
5. So WY, Kong AP, Ma RC et al.: Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006; 29(9): 2046-2052.
6. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę. Diabetologia Kliniczna 2013; 2 (Supl. A): A1-A70.
